Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety and tolerability of EC-MPS in maintenance
renal transplant patients who experience gastrointestinal (GI) intolerance due to adverse
events associated with mycophenolate mofetil (MMF) and were converted to EC-MPS.